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INTRODUCTION
Nitric oxide (NO) is one of important mediators of urinary
sodium excretion. It may increase the excretion of sodium
in the absence of changes in renal hemodynamics (1), suggest-
ing a tonic inhibitory effect on the tubular reabsorption of
sodium in kidney. Furthermore, its modulating action on
tubular sodium reabsorption is exerted through regulating
the membrane sodium transporters. 
In the kidney, active reabsorption of sodium occurs in most
parts of the tubule through the activity of Na, K-ATPase. It
provides the driving force for sodium movement in the baso-
lateral membrane, transporting sodium out of the cell into
the interstitium (2). On the contrary, the luminal entry of
sodium into the cells occurs through different transporters.
Type 3 Na/H exchanger (NHE3) is apically expressed in the
proximal tubule (3), whereas the thiazide-sensitive Na/Cl
cotransporter (TSC) is involved in apical sodium reabsorption
in the distal convoluted tubule (4). In the thick ascending
loop of Henle (TALH), Na/K/2Cl cotransporters (BSC1) and
NHE3 are mainly responsible for sodium reabsorption (5).
NO has been shown to inhibit both Na/H exchange (6) and
Na,K-ATPase activity in proximal tubule cells (7). It has been
also demonstrated to inhibit Na-K-ATPase in TALH (8). In
the isolated perfused rat TALH, NO donors selectively inhibit
the apical BSC1 (8, 9). An altered regulation of these sodium
transporters may underlie the salt-sensitive hypertension asso-
ciated with chronic NO blockade (10-12). 
The present study was thus aimed to determine whether
NO exerts a tonic regulatory effect on the expression of sodi-
um transporters in the kidney. Rats were treated with NO
synthase (NOS) inhibitor, N
G-nitro-L-arginine methyl ester
(L-NAME), for 4 weeks, and the expression of Na, K-ATPase,
NHE3, BSC-1, and TSC proteins was determined in the kid-
ney by Western blot analysis.
MATERIALS AND METHODS
Animals and renal function
Male Sprague-Dawley rats (200-250 g) were used. All pro-
cedures were done in accordance with Institutional Guidelines
for Laboratory Animal Care and Use. Experimental group of
rats was treated with L-NAME (100 mg/L drinking water)
for 4 weeks. Control group was supplied with tap water with-
out any drugs. Systolic blood pressure (SBP) was indirectly
measured every week in a conscious state by tail-cuff method.
For the collection of urinary data, the rats were anesthetized
with pentobarbital sodium (50 mg/kg, intraperitoneal on the
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Increased Expression of Sodium Transporters in Rats Chronically
Inhibited of Nitric Oxide Synthesis
The present study was done to determine whether endogenous nitric oxide (NO)
plays a role in the regulation of sodium transporters in the kidney. Male Sprague-
Dawley rats were treated with N
G-nitro-L-arginine methyl ester (L-NAME, 100 mg/L
drinking water) for 4 weeks. Control rats were supplied with tap water without drugs.
Expression of Na, K-ATPase, type 3 Na/H exchanger (NHE3), Na/K/2Cl cotransporter
(BSC1), and thiazide-sensitive Na/Cl cotransporter (TSC) proteins was determined
in the kidney by Western blot analysis. Catalytic activity of Na,K-ATPase was also
determined. The treatment with L-NAME significantly and steadily increased the
systemic blood pressure. Total and fractional excretion of urinary sodium decreased
significantly, while creatinine clearance remained unaltered. Neither plasma renin
activity nor aldosterone concentration was significantly altered. The  1subunit ex-
pression and the catalytic activity of Na, K-ATPase were increased in the kidney.
The expression of NHE3, BSC1 and TSC was also increased significantly. These
results suggest that endogenously-derived NO exerts a tonic inhibitory effect on
the expression of sodium transporters, including Na, K-ATPase, NHE3, BSC1, and
TSC, in the kidney.
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experimental day. The urinary bladder was exposed through
a low midline abdominal incision and cannulated with PE
50 tubing to collect urine samples for 2 hr. At the end of urine
collection, the arterial blood was collected. Creatinine clear-
ance, urinary sodium excretion and fractional excretion of so-
dium were measured. 
To determine plasma renin activity (PRA) and aldosterone
level, the trunk blood was collected by the decapitation in a
conscious state. For renin activity, the generation of Ang I was
measured using a kit from New England Nuclear (Boston,
MA, U.S.A.). For aldosterone, Coat A-Count kit was used
(Diagnostic Products; Los Angeles, CA, U.S.A.).
Na,K-ATPase activity
The catalytic activity of Na, K-ATPase was determined by
a coupled enzyme optical assay as described previously (13).
The tissue fraction was added to the assay mixture including
enzymes and other cofactors: KCl 20 mM, NaCl 130 mM,
MgCl2 4 mM, ATP 3 mM, phospho [enol] pyruvate 1 mM,
NADH 0.2 mM, pyruvate kinase 10 U, lactate dehydroge-
nase 30 U/mL and histidine 30 mM. To determine ouabain-
insensitive ATPase activity, identical assay mixture added
with 1 mM ouabain was used. ATP-disodium salt (5 mM), as
substrate, was added to start the reaction. The absorbance
was read at 340 nm at 37℃for 2 min. The ouabain-sensitive
activity was calculated by subtracting the activity measured
in the presence of ouabain from the total activity. The activi-
ty was expressed as micromoles of ATP hydrolysed per mg
of protein per min.
Protein preparation and Western blot analysis
The kidneys were rapidly isolated following the decapita-
tion under a conscious state. They were rapidly frozen and kept
at -70℃ until assayed. The kidney was homogenized with
Polytron homogenizer at 3,000 rpm in a solution containing
sucrose (250 mM), EDTA (1 mM), phenylmethylsulfonyl
fluoride (0.1 mM), and potassium phosphate buffer (20 mM),
at pH 7.6. The homogenate was centrifuged at 1,000 g for
15 min to remove whole cells, nuclei and mitochondria. The
supernatant was then ultracentrifuged at 100,000 g for 1 hr
to produce a pellet containing membrane fractions enriched
for both plasma membranes and intracellular vesicles. The
pellet was resuspended in homogenizing solution for protein
blotting. 
Protein samples (100  g) were loaded and electrophoretical-
ly size-separated with a discontinuous system consisting of 8-
12.5% polyacrylamide resolving gel and 5% polyacrylamide
stacking gel. The proteins were then electrophoretically trans-
ferred to a nitrocellulose membrane at 40 V for 3 hr. The
membranes were washed in Tris-based saline buffer (pH 7.4)
containing 0.1% Tween-20 (TBST), blocked with 5% nonfat
milk in TBST for 1 hr, and incubated with 1:2,500 dilutions
of polyclonal rabbit anti  -1 and  -1 subunits of Na,K ATPase
(Upstate Biotechnology; Lake Placid, NY, U.S.A.), 1:750
dilutions of polyclonal rabbit anti NHE-3 (Alpha Diagnos-
tic; San Antonio, TX, U.S.A.), 1:100 dilutions of polyclonal
rabbit anti BSC-1 and TSC (Chemicon; Temecula, CA, U.S.A.)
in 2% nonfat milk/TBST for 1 hr at room temperature. The
membranes were then incubated with a horseradish peroxi-
dase-labeled goat anti-rabbit IgG (1:1,200) in 2% nonfat
milk in TBST for 2 hr. The bound secondary antibody was
detected by enhanced chemiluminescence (Amersham; Buck-
inghamshire, England). The protein levels were determined
by analyzing the autoradiogram signals using the transmit-
ter scanning videodensitometer.
Drugs and statistical analysis 
Drugs were purchased from Sigma Chemical Company (St.
Louis, MO, U.S.A.) unless stated otherwise. Results are ex-
pressed as mean±SEM. The statistical significance of differ-
ences between the groups was determined using unpaired t-
test. 
RESULTS
Renal functional parameters
A steady-state hypertension was observed following the treat-
ment with L-NAME. SBP measured on the 4th week day was
165±4 mmHg in the experimental group, while it was 122
±5 mmHg in the control (n=6 each, p<0.05). Table 1 sum-
marizes the renal functional data. Total and fractional excre-
tion of sodium decreased significantly, while creatinine clear-
ance and urinary flow rate remained unaltered. PRA and the
plasma aldosterone level were not significantly altered. 
Expression of Na,K-ATPase 
The  1-isoform specific monoclonal antibody of Na,K-
ATPase recognized a band at about 110 kDa. The  1-iso-
form antibody recognized a band at 52 kDa. Following L-
Control
PRA (ngAI/mL/hr) 4.6±1.1 3.4±0.5
Aldosterone (ng/dL) 7.8±1.7 7.4±0.9
Urinary flow rate ( L/min) 12.4±3.1 9.8±2.2
Ccr (mL/min/kg) 2.5±0.3 2.4±0.4
FENa (%) 0.67±0.06 0.43±0.08*
UNaV ( Eq/min/kg) 2.05±0.11 1.47±0.03*
Table 1. Plasma hormone levels and renal functional para-
meters
L-NAME
Data are mean±SEM. N=6 each. PRA, plasma rennin activity; Ccr, cre-
atinine clearance; FENa, fractional excretion of sodium; UNaV, urinary sodi-
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NAME treatment, the expression of  1 subunit of Na,K-
ATPase was increased, although that of  1 subunit was not
significantly altered (Fig. 1). Accordingly, the catalytic activi-
ty of Na,K-ATPase was increased (Fig. 2). 
Expression of NHE3, BSC1 and TSC
Fig. 3, 4 show immunoblots of NHE3, BSC1 and TSC,
using the membrane preparation of the whole kidney. Affini-
ty purified anti-NHE3 antibody recognized a band at about
87 kDa. Affinity purified anti-BSC1 antibody recognized a
broad band of molecular mass at 146-176 kDa. Affinity puri-
fied anti-TSC antibody recognized a broad band centered at
about 165 kDa. The expression of these transporters was in-
creased significantly following the treatment with L-NAME.
DISCUSSION
The treatment with L-NAME induced a steady-state hyper-
tension from the first week of measurement, as in our previ-
ous study (14). Accordingly, the total and fractional urinary
Fig. 4. Expression of BSC-1 and TSC. Each column represents
the mean±SEM of 5 rats. *p<0.05, p<0.01; compared with
control.
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Fig. 1. Expression of  1and  1subunits of Na,K-ATPase. Rep-
resentative immunoblots and densitometric data are shown. Sym-
bols are: (    ) control and (   ) L-NAME-treatment. Each column
represents the mean±SEM of 6 rats. *p<0.05, compared with
control.
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Fig. 2. Na,K-ATPase activity. Symbols are: (    ) control and (    )
L-NAME-treatment. Each column depicts the mean±SEM of 6
rats. **p<0.01, compared with control. 
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Fig. 3. Expression of NHE3. Each column represents the mean
±SEM of 6 rats. **p<0.01, compared with control. 
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excretion of sodium decreased, while creatinine clearance re-
mained unaltered. These findings support the notion that
L-NAME induces a salt-sensitive hypertension associated
with increased sodium balance (10-12). 
It has been known that NO can inhibit sodium transport
in the nephron, which may account for the natriuresis obser-
ved in vivo. For instance, sodium nitroprusside, an exogenous
NO donor, significantly inhibited the activity of Na,K-ATPase
in vitro (15). NO also has an inhibitory effect on both Na/H
exchange and Na,K-ATPase activity in the proximal tubule
(16, 17). The inhibited chloride absorption by TALH is mi-
micked by basolateral administration of L-arginine and is
inhibited by L-NAME (18). It has been also found that NO
inhibits the activity of BSC1 in TALH and MMDD1 cells
(19, 20). 
Following the treatment with L-NAME, the renal expres-
sion of  1subunit of Na,K-ATPase was increased. Accord-
ingly, the catalytic activity of Na,K-ATPase was increased.
The expression of NHE3 and BSC1 also increased. The in-
creased expression of these transporters may represent a remo-
val of tonic inhibitory effect of NO on these transporters. 
On the other hand, the sodium transport in distal nephron
is activated by mineralocorticoids, in part through increas-
ing the expression of TSC (21). However, the abundance of
TSC was increased following the treatment with L-NAME,
while the plasma aldosterone level remained unchanged in
the present study. It is suggested that there exists a direct
tonic inhibitory effect of NO on the expression of TSC.
In summary, the expression of sodium transporters, such
as NHE3, BSC1, and TSC, was increased along with the ex-
pression and catalytic activity of Na,K-ATPase following a
chronic blockade of NO synthesis. It is suggested that the
endogenous NO plays a regulatory role in the expression of
sodium transporters in the kidney with tonic inhibition. The
L-NAME-induced hypertension may in part be causally relat-
ed with the upregulation of these sodium transporters, cul-
minating in increased tubular reabsorption and retention of
sodium.
REFERENCES
1. Lahera V, Salom MG, Fiksen-Olsen MJ, Raij L, Romero JC. Effects
of N
G-monomethyl-L-arginine and L-arginine on acetylcholine res-
ponse. Hypertension 1990; 15: 659-63.
2. Kashgarian M, Biemesderfer D, Caplan M, Forbush B 3rd. Mono-
clonal antibody to Na, K-ATPase: immunocytochemical localization
along nephron segments. Kidney Int 1985; 28: 899-913.
3. Amemiya M, Loffing J, Lotscher M, Kaissling B, Alpern RJ, Moe
OW. Expression of NHE-3 in the apical membrane of rat renal proxi-
mal tubule and thick ascending limb. Kidney Int 1995; 48: 1206-15.
4. Gamba G, Miyanoshita A, Lombardi M, Lytton J, Lee WS, Hediger
MA, Hebert SC. Molecular cloning, primary structure, and charac-
terization of two members of the mammalian electroneutral sodium-
(potassium)-chloride cotransporter family expressed in kidney. J Biol
Chem 1994; 269: 17713-22.
5. Knepper MA, Kim GH, Fernandez Llama P, Ecelbarger C. Regula-
tion of thick ascending limb transport by vasopressin. J Am Soc
Nephrol 1999; 10: 628-34. 
6. Roczniak A, Burns KD. Nitric oxide stimulates guanylate cyclase and
regulates sodium transport in rabbit proximal tubule. Am J Physiol
1996; 270: F106-15.
7. McKee M, Scavone C, Nathanson JA. Nitric oxide, cGMP, and hor-
mone regulation of active sodium transport. Proc Natl Acad Sci USA
1994; 91: 12056-60.
8. Varela M, Herrera M, Garvin JL. Inhibition of Na-K-ATPase in thick
ascending limbs by NO depends on O2
- and is diminished by a high-
salt diet. Am J Physiol Renal Physiol 2004; 287:F224-30.
9. Ortiz PA, Hong NJ, Garvin JL. NO decreases thick ascending limb
chloride absorption by reducing Na
+-K
+-2Cl
- cotransporter activity.
Am J Physiol Renal Physiol 2001; 281: F819-F25.
10. Nakanishi K, Hara N, Nagai Y. Salt-sensitive hypertension in con-
scious rats induced by chronic nitric oxide blockade. Am J Hyper-
tens 2002; 15: 150-6.
11. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T. Salt-in-
duced increase in arterial pressure during nitric oxide synthesis
inhibition. Hypertension 1993; 22: 49-55.
12. Nakanishi K, Mattson DL, Cowley AW Jr. Role of renal medullary
blood flow in the development of L-NAME hypertension in rats. Am
J Physiol 1995; 268: R317-23.
13. Norby JG. Coupled assay of Na
+,K
+-ATPase activity. Methods Enzy-
mol 1988; 156: 116-9.
14. Lee J, Choi KC, Yeum CH, Kim W, Yoo K, Park JW, Yoon PJ. Im-
pairment of endothelium-dependent vasorelaxation in chronic two-
kidney, one clip hypertensive rats. Nephrol Dial Transplant 1995; 10:
619-23.
15. Kang DG, Kim JW, Lee J. Effects of nitric oxide synthesis inhibition
on the Na,K-ATPase activity in the kidney. Pharmacol Res 2000; 41:
123-27.
16. Roczniak A, Burns KD. Nitric oxide stimulates guanylate cyclase and
regulates sodium transport in rabbit proximal tubule. Am J Physiol
1996; 270: F106-15.
17. Stoos BA, Garvin JL. Actions of nitric oxide on renal epithelial trans-
port. Clin Exp Pharmacol Physiol 1997; 24: 591-4.
18. Plato CF, Stoos BA, Wang D, Garvin JL. Endogenous nitric oxide
inhibits chloride transport in the thick ascending limb. Am J Physiol
1999; 276: F159-63.
19. Ortiz PA, Hong NJ, Garvin JL. NO decreases thick ascending limb
chloride absorption by reducing Na
+-K
+-2Cl
- cotransporter activity.
Am J Physiol Renal Physiol 2001; 281: F819-25.
20. He H, Podymow T, Zimpelmann J, Burns KD. NO inhibits Na
+-K
+-
2Cl
-cotransport via a cytochrome P-450-dependent pathway in renal
epithelial cells (MMDD1). Am J Physiol 2003; 284: F1235-44.
21. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper
MA. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-
induced protein. Proc Natl Acad Sci USA 1998; 95: 14552-7.